Inventor
Qingfeng XING
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations44%
C07DHeterocyclic compounds44%
A61KPreparations for medical, dental or toiletry purposes11%
PatentTitleYear
12,365,685Substituted fused aromatic ring derivative, composition and use thereof202511,840,535Alkynyl(hetero)aromatic compound for inhibiting protein kinase activity202311,746,110Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activity202311,186,578Substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines as tyrosine kinase inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to SHENZHEN TARGETRX INC (4)· patent assignee history
2021–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHENZHEN TARGETRX INC | 4 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2021–2025 |